Chimeric antigen receptor-modified T cells therapy in prostate cancer: A comprehensive review on the current state and prospects
Author:
He MingzeORCID,
Zhang Dongqi,
Cao YuORCID,
Chi Changliang,
Zeng Zitong,
Yang Xinyi,
Yang Guodong,
Sharma Kritika,
Hu Kebang,
Enikeev MikhailORCID
Subject
Multidisciplinary
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献